177 related articles for article (PubMed ID: 35274173)
41. Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer.
Duus LA; Junker T; Rasmussen BS; Bojsen JA; Pedersen AL; Anthonsen A; Lund L; Pedersen M; Graumann O
Acta Radiol; 2023 Feb; 64(2):814-820. PubMed ID: 35297745
[TBL] [Abstract][Full Text] [Related]
42. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
43. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.
Mason RJ; Atwell TD; Lohse C; Bhindi B; Weisbrod A; Boorjian SA; Leibovich BC; Schmit GD; Thompson RH
BJU Int; 2017 Oct; 120(4):544-549. PubMed ID: 28548236
[TBL] [Abstract][Full Text] [Related]
44. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
[TBL] [Abstract][Full Text] [Related]
45. Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis.
Klatte T; Mauermann J; Heinz-Peer G; Waldert M; Weibl P; Klingler HC; Remzi M
J Endourol; 2011 Jun; 25(6):991-7. PubMed ID: 21568698
[TBL] [Abstract][Full Text] [Related]
46. Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2-4 cm: A population-based study.
Yan S; Yang W; Zhu CM; Yan PM; Wang ZC
Medicine (Baltimore); 2019 May; 98(21):e15610. PubMed ID: 31124938
[TBL] [Abstract][Full Text] [Related]
47. Percutaneous image-guided cryoablation with temporary balloon occlusion of the renal artery for the treatment of central renal tumors.
Autrusseau PA; Boatta E; Cazzato RL; Auloge P; Mayer T; Weiss J; Koch G; Caudrelier J; De Marini P; Gangi A; Garnon J
Diagn Interv Imaging; 2022 Nov; 103(11):510-515. PubMed ID: 35934617
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
[No Abstract] [Full Text] [Related]
49. Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy
Uemura T; Kato T; Nagahara A; Kawashima A; Hatano K; Ujike T; Ono Y; Higashihara H; Fujita K; Fukuhara S; Kiuchi H; Imamura R; Tomiyama N; Nonomura N; Uemura M
In Vivo; 2021; 35(3):1573-1579. PubMed ID: 33910838
[TBL] [Abstract][Full Text] [Related]
50. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
Zhou W; Herwald SE; Uppot RN; Arellano RS
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
[TBL] [Abstract][Full Text] [Related]
51. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma.
Minervini A; Campi R; Di Maida F; Mari A; Montagnani I; Tellini R; Tuccio A; Siena G; Vittori G; Lapini A; Raspollini MR; Carini M
Urol Oncol; 2018 Dec; 36(12):527.e1-527.e11. PubMed ID: 30268711
[TBL] [Abstract][Full Text] [Related]
52. Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses.
Murray CA; Welch BT; Schmit GD; Schmitz JJ; Weisbrod AJ; Callstrom MR; Welch TL; Thompson RH; Kurup AN; Boorjian SA; Atwell TD
Urology; 2019 Nov; 133():151-156. PubMed ID: 31415781
[TBL] [Abstract][Full Text] [Related]
53. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
[TBL] [Abstract][Full Text] [Related]
54. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
55. Percutaneous radiofrequency ablation is an effective treatment option for small renal masses, comparable to partial nephrectomy.
Pedraza-Sánchez JP; Chaves-Marcos R; Mazuecos-Quirós J; Bisonó-Castillo ÁL; Osmán-García I; Gutiérrez-Marín CM; Medina López RA; Juárez Soto Á
Eur Radiol; 2023 Nov; 33(11):7371-7379. PubMed ID: 37280356
[TBL] [Abstract][Full Text] [Related]
56. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
[TBL] [Abstract][Full Text] [Related]
57. Synchronous nephron-sparing approaches for bilateral renal masses: peri-operative and renal functional outcomes.
Mason RJ; Atwell T; Lohse C; Bhindi B; Schmit G; Schmitz J; Leibovich BC; Boorjian SA; Thompson RH
BJU Int; 2018 Aug; 122(2):243-248. PubMed ID: 29603885
[TBL] [Abstract][Full Text] [Related]
58. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
59. Laparoscopic cryoablation for renal cell carcinoma: 100-Month oncologic outcomes. Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O'Malley C, Remer EM, Kaouk JH. J Urol. 2015 Oct;194(4):892-896. [Epub 2015 April 23]. doi: 10.1016/j.juro.2015.03.128.
Meng M
Urol Oncol; 2017 May; 35(5):311-312. PubMed ID: 28359745
[TBL] [Abstract][Full Text] [Related]
60. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study.
Umakoshi N; Iguchi T; Matsui Y; Tomita K; Uka M; Kawabata T; Munetomo K; Nagata S; Gobara H; Araki M; Hiraki T
Jpn J Radiol; 2023 Sep; 41(9):1007-1014. PubMed ID: 37002430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
